Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 3257042)

1.

[Studies on a sustained release procainamide hydrochloride tablet--an oral osmotic pump].

Zhu YP, Mao FF, Tu XD.

Yao Xue Xue Bao. 1988 Nov;23(11):850-6. Chinese. No abstract available.

PMID:
3257042
2.

Absorption kinetics of procainamide in humans.

Manion CV, Lalka D, Baer DT, Meyer MB.

J Pharm Sci. 1977 Jul;66(7):981-4.

PMID:
886461
3.

Comparative bioavailability of two oral sustained-release procainamide products.

Baker BA, Reynolds JR, Gleckel L, A'Zary E, Bodenheimer MM.

Clin Pharm. 1988 Feb;7(2):135-8.

PMID:
3349748
4.

A new sustained-release tablet formulation of procainamide.

Fremstad D, Dahl S, Jacobsen S, Lunde PK, Nådland KJ, Marthinsen AA, Waaler T, Landmark KH.

Eur J Clin Pharmacol. 1973 Dec;6(4):251-5. No abstract available.

PMID:
4591152
5.

Pharmaceutical and pharmacokinetic principles in the formulation of a sustained-release procainamide tablet.

Dahl SG, Fremstad D, Jacobsen S, Kvaleid I, Landmark KH, Lunde PK, Marthinsen AA, Nådland KJ, Waaler T.

Pharm Acta Helv. 1976;51(7-8):204-8. No abstract available.

PMID:
967912
6.

Effect of age, gender, and race on steady state procainamide pharmacokinetics after administration of procanbid sustained-release tablets.

Koup JR, Abel RB, Smithers JA, Eldon MA, de Vries TM.

Ther Drug Monit. 1998 Feb;20(1):73-7.

PMID:
9485559
7.

Procainamide in acute myocardial infarction: a study on two different tablet preparations of sustained release type.

Ihlen H, Ditlefsen L.

Curr Ther Res Clin Exp. 1975 Nov;18(5):720-6. No abstract available.

PMID:
812650
8.

Sustained release procainamide in patients with myocardial infarction.

Birkhead J, Evans T, Mumford P, Martinez E, Jewitt D.

Br Heart J. 1976 Jan;38(1):77-80.

9.

Procainamide-induced pseudo-obstruction in a diabetic patient.

Peterson AM, Conrad SD, Bell JM.

DICP. 1991 Dec;25(12):1334-5.

PMID:
1815428
10.
11.

Comparable steady-state bioavailability between two preparations of conventional-release procainamide hydrochloride.

Kasmer RJ, Nara AR, Green JA, Chawla AK, Fleming GM.

Drug Intell Clin Pharm. 1987 Feb;21(2):183-6.

PMID:
3829910
12.

Agranulocytosis due to new sustained-release procainamide.

Berger BE, Hauser DJ.

Am Heart J. 1983 Jun;105(6):1035-6. No abstract available.

PMID:
6858823
13.

[Study on dissolution test in vitro and bioavailability of oral osmotic pump of verapamil hydrochloride].

Guo JL, Jing GW, Cao DS, Li YQ, He HY, Ling LX, Li Z.

Yao Xue Xue Bao. 1993;28(9):714-20. Chinese.

PMID:
8010021
15.

Bioequivalency of sustained-release procainamide.

Hull RL.

Drug Intell Clin Pharm. 1984 Jun;18(6):531. No abstract available.

PMID:
6734442
16.
17.

Experiences on a sustained-release procainamide preparation.

Ruosteenoja R, Torsti P, Sothmann A.

Curr Ther Res Clin Exp. 1973 Oct;15(10):707-12. No abstract available.

PMID:
4201315
18.

Severe neutropenia due to sustained-release procainamide.

Hoyt RE.

South Med J. 1987 Sep;80(9):1196-7.

PMID:
3629327
19.
20.

Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.

Vlasses PH, Rocci ML Jr, Porrini KA, Greenspon AJ, Ferguson RK.

Ann Intern Med. 1983 May;98(5 Pt 1):613-4. No abstract available.

PMID:
6189438
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk